Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update

Edwards Lifesciences Corporation (NYSE:EW) is one of the best medical technology stocks to invest in. On February 11, Stifel reiterated its Buy rating on Edwards Lifesciences and kept its price target at $110. Stifel made the move right after Edwards Lifesciences shared its Q4 2025 earnings on February 10. The results showed that quarterly sales went up by 11.6% to $1.57 billion and beat Stifel and consensus estimates of $1.54 billion and $1.55 billion, respectively. Edwards Lifesciences Corporation (EW) ...